October 14, 2026

Skin odor signatures may shift with age

Investigators linked distinct odor patterns to life stage, sex, and skin microbes, while limited longitudinal evidence leaves their clinical utility uncertain.

MDSpire News

October 09, 2026

FDA approves atezolizumab for dMMR colon cancer

In the phase 3 ATOMIC trial, adjuvant atezolizumab plus chemotherapy halved the risk of recurrence or death in stage 3 patients.

MDSpire News

October 09, 2026

Medical debt linked to higher late-stage cancer rates

Lung cancer showed the strongest absolute association, while prostate and breast cancer findings diverged from the broader pattern.

MDSpire News

October 07, 2026

FDA grants Temab-A dual Breakthrough status

The designations cover refractory metastatic CRC and previously treated c-Met–expressing NSCLC.

MDSpire News

September 30, 2026

Misleading AI summaries may alter recall

Participants exposed to inaccurate postevent summaries were less likely to correctly remember key details from videos they had previously watched.

MDSpire News

September 30, 2026

Vitamin D may ease cancer treatment skin toxicity

Most patients reported symptom relief within 10 days, while 73% continued anticancer therapy without interruption.

MDSpire News

September 29, 2026

Dietary fat type may matter after prostate cancer

The association was driven by cardiovascular disease and other cancers, not prostate cancer mortality.

MDSpire News

September 28, 2026

Trends in alcohol-linked cancer mortality

Investigators examined 3 decades of US cancer mortality estimates across age, sex, region, and cancer type.

MDSpire News

September 28, 2026

ACS report: Lung cancer deaths plunge as survival doubles

Lung cancer deaths fell by more than half among US males as smoking declined, earlier-stage diagnoses increased, and 5-year relative survival doubled.

MDSpire News

September 25, 2026

FDA monthly preview: Key October decisions to watch

Several FDA decisions across multiple specialties are expected this month.

MDSpire News